Procaps Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jose Antonio Vieira

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	4.5yrs
Board average tenure	1.4yrs

Recent management updates

Recent updates

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Mar 28

CEO

Jose Antonio Vieira (58 yo)

less than a year

Tenure

Mr. Jose Antonio Toledo Vieira is Chief Executive Officer of Procaps Group S.A. from January 15, 2024. He has been Member of Advisory Board at Patria Latin American Opportunity Acquisition Corp. since 2022...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jose Antonio Vieira	Chief Executive Officer	less than a year	no data	no data
Patricio Munoz	Global Chief Financial Officer	3.3yrs	no data	no data
Camilo Camacho	Chief Operations Officer	no data	no data	no data
Melissa Angelini	Investor Relations Director	2.8yrs	no data	no data
Marcela Pagano	Vice-President of Corporate & Legal Affairs	11.8yrs	no data	no data
Luis Alberto Aragon	Vice-President of International Marketing and R&D	5.8yrs	no data	no data
Mauricio Caballero	Vice-President of Human Resources	10.3yrs	no data	no data

4.5yrs

Average Tenure

54yo

Average Age

Experienced Management: PROC's management team is considered experienced (4.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Daniel Fink	Board Observer	1.8yrs	no data	no data
Jose Gontovnik	Chairman	less than a year	no data	15.92% $ 12.4m
Kyle Bransfield	Independent Director	3.2yrs	no data	1.81% $ 1.4m
David Yanovich Wancier	Independent Director	no data	no data	no data
Alberto Eguiguren Correa	Independent Director	1.8yrs	no data	no data
Luis Castro Vergara	Independent Director	no data	no data	no data
Sandra Sanchez Oldenhage	Independent Director	1.1yrs	no data	no data
Roberto Albisetti	Independent Director	less than a year	no data	no data

1.4yrs

Average Tenure

55yo

Average Age

Experienced Board: PROC's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.

Procaps Group Management

Management criteria checks 1/4

Key information

Recent management updates

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Recent updates

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Hoche Partners Raises Concerns on Shareholder Letter Issued by Procaps Group

Hoche Partners Criticizes Procaps Group's Majority Shareholder for Mismanagement and Rejection of Financial Restructuring Offer

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

Is Procaps Group S.A. (NASDAQ:PROC) Worth US$3.7 Based On Its Intrinsic Value?

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Investor sentiment deteriorates as stock falls 17%

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 19%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Consensus EPS estimates fall by 28%

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)

Investor sentiment deteriorates as stock falls 16%

Procaps Group Announces Key Changes to the Board of Directors

Price target increased to US$13.00

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Now 22% undervalued after recent price drop

Now 23% undervalued after recent price drop

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Procaps Group reports Q2 results

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: EPS: US$0.16 (vs US$0.18 loss in 1Q 2021)

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Forecast to breakeven in 2022

Now 20% undervalued after recent price drop

Forecast to breakeven in 2022

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Calculating The Fair Value Of Procaps Group, S.A. (NASDAQ:PROC)

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age